Restoration of the expression of transporters associated with antigen processing in lung carcinoma increases tumor-specific immune responses and survival

Cancer Research

Volumn 65, Issue 17, 2005, Pages 7926-7933

  Lou, Yuanmei ^a   Vitalis, Timothy Z ^a   Basha, Genc ^a   Cai, Bing ^a   Chen, Susan S ^a   Choi, Kyung Bok ^a   Jeffries, Andrew P ^a   Elliott, W Mark ^b   Atkins, Derek ^c   Seliger, Barbara ^d   Jefferies, Wilfred A ^a,e  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ST PAUL S HOSPITAL   (Canada)

^c Institute of Pathology   (Germany)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BETA 2 MICROGLOBULIN; COMPLEMENTARY DNA; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TAPASIN; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1;

ADULT; AGED; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CLINICAL ARTICLE; CROSS PRESENTATION; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; TUMOR ASSOCIATED LEUKOCYTE; VIRUS RECOMBINANT;

ADENOVIRIDAE; AGED; ANTIGEN PRESENTATION; ANTIPORTERS; ATP-BINDING CASSETTE TRANSPORTERS; BETA 2-MICROGLOBULIN; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CELL LINE, TUMOR; DENDRITIC CELLS; FEMALE; HLA ANTIGENS; HUMANS; IMMUNOGLOBULINS; INTERFERON TYPE II; LUNG NEOPLASMS; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; SPLEEN;

EID: 24744462113     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-3977     Document Type: Article

References (29)

1. Berzofsky JA, Terabe M, Oh S, et al. Progress on new vaccine strategies for the immunotherapy and prevention of cancer. J Clin Invest 2004;113:1515-25.
2. Gilboa E. The promise of cancer vaccines. Nat Rev Cancer 2004;4:401-11.
3. Marincola FM, Wang E, Herlyn M, Seliger B, Ferrone S. Tumors as elusive targets of T cell-based active immunotherapy. Trends Immunol 2003;24:335-42.
4. Cabrera T, Salinero J, Fernandez MA, Garrido A, Esquivias J, Garrido F. High frequency of altered HLA class I phenotypes in laryngeal carcinomas. Hum Immunol 2000;61:499-506.
5. Koopman LA, Corver WE, Van der Slik AR, Giphar MJ, Fleuren GJ. Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer. J Exp Med 2000;20:961-76.
6. Seliger B, Maeurer MJ, Ferrone S. Antigen-processing machinery breakdown and tumor growth. Immunol Today 2000;21:455-64.
7. Dissemond J, Gotte P, Mors J, et al. Association of TAP1 downregulation in human primary melanoma lesions with lack of spontaneous regression. Melanoma Res 2003;13:253-8.
8. Seliger B, Ritz U, Abele R, et al. Immune escape of melanoma: first evidence of structural alterations in two distinct components of the MHC class I antigen processing pathway. Cancer Res 2001;61:8647-50.
9. Singal DP, Ming YE, Bienzle D. Transfection of TAP 1 gene restores HLA class I expression in human small-cell lung carcinoma. Int J Cancer 1998;75:112-6.
10. Franks LM, Carbonell AW, Hemmings VJ, Riddle PN. Metastasizing tumors from serum-supplemented and serum-free cell lines from a C57BL mouse lung tumor. Cancer Res 1976;36:1049-55.
11. Jefferries WA, Kolaitis G, Gabathuler R. IFN-γ-induced recognition of the antigen-processing variant CMT.64 by cytolytic T cells can be replaced by sequential addition of β2 microglobulin and antigenic peptides. J Immunol 1993;151:2974-85.
12. Gabathuler R, Reid G, Kolaitis G, Driscoll J, Jefferies WA. Comparison of cell lines deficient in antigen presentation reveals a functional role for TAP-1 alone in antigen processing. J Exp Med 1994;180:1415-25.
13. Johnsen AK, Templetion DJ, Sy MS, Harding CV. Deficiency of transporter for antigen presentation (TAP) in tumor cells allows evasion of immune surveillance and increases tumorigenesis. J Immunol 1999;163:4224-31.
14. Alimonti J, Zhang QJ, Gabathuler R, Reid G, Chen SS, Jefferies WA. TAP expression provides a general method for improving the recognition of malignant cells in vivo. Nat Biotechnol 2000;18:515-20.
15. Ding L, Quinlan KB, Elliott WM, et al. A lung tissue bank for gene expression studies in chronic obstructive pulmonary disease. J Chronic Obstr Pulm Dis 2004;1:191-204.
16. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350:2645-53.
17. Seliger B, Atkins D, Bock M, et al. Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen processing down-regulation. Clin Cancer Res 2003;9:1721-7.
18. Hardy S, Kitamura S, Harris-Stansil T, Dai Y, Phipps ML. Construction of adenovirus vectors through cre-lox recombination. J Virol 1997;71:1842-9.
19. Mittereder N, March KL, Trapnell BC. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J Virol 1996;70:7498-509.
20. Mandelboim O, Bar-Haim E, Vadai E, Fridkin M, Eisenbach L. Identification of shared tumor-associated antigen peptides between two spontaneous lung carcinomas. J Immunol 1997;159:6030-6.
21. Porgador A, Yewdell JW, Deng Y, Bennink JR, Germain RN. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 1997;6:715-26.
22. Rodriguez A, Regnault A, Kleijmeer M, Ricciardi-Castagnoli P, Amigorena S. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat Cell Biol 1999;1:362-8.
23. Roederer M, Moore W, Treister A, Hardy RR, Herzenberg LA. Probability binning comparison: a metric for quantitating multivariate distribution differences. Cytometry 2001;45:47-55.
24. Cox C, Reeder JE, Robinson RD, Suppes SB, Wheeless LL. Comparison of frequency distributions in flow cytometry. Cytometry 1988;9:291-8.
25. Korkolopoulou P, Kaklamanis L, Pezzella F, Harris AL, Gatter KC. Loss of antigen-presenting molecules (MHC class 1 and TAP-1) in lung cancer. Br J Cancer 1996;73:148-53.
26. Fine CI, Han CD, Sun X, Liu Y, McCutcheon JA. Tobacco reduces membrane HLA class I that is restored by transfection with transporter associated with antigen processing 1 cDNA. J Immunol 2002;169:6012-9.
27. Jacobs BL, Langland JO. When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology 1996;219:339-49.
28. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 2001;413:732-8.
29. Purbhoo MA, Irvine DJ, Huppa JB, Davis MM. T cell killing does not require the formation of a stable mature immunological synapse. Nat Immunol 2004;5:524-30.